(Q33577818)
Statements
1 reference
Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysis (English)
1 reference
Bradley J Monk
1 reference
John K Chan
1 reference
Thomas J Herzog
1 reference
Lilian Hu
1 reference
Tuyen Kiet
1 reference
Kevin Blansit
1 reference
Daniel S Kapp
1 reference
Xinhua Yu
1 reference
10 April 2014
1 reference
1 reference
19
1 reference
523-527
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference